BMY and AZN Related Headlines
Go Back- A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
- 'No Discussions' Over Astrazeneca-Bristol Myers Deal, Senior Source Says - Reuters
- Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
- AstraZeneca reviews potential Bristol Myers deal, Barclays comments
- Bernstein on IRA pricing: $245 really is the floor
